диссертации / 27
.pdf62.De Murcia G., Menissier de Murcia J. Poly(ADP-ribose) polymerase: a molecular nick-sensor // Trends Biochem. Sci. – 1994 – Vol.19. – P.172176.
63.De Murcia G., Schreiber V., Molinete M., et al. Structure and function of Poly(ADP-ribose) polymerase // Mol. Cell Biochem. – 1994. –Vol.138. – P.15-24.
64.Desnick R.J., Brady R., Barranger J., et al. Fabry disease, an underrecognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy // Ann. Intern. Med. – 2003.
– Vol. 138. – P.338-346.
65.Diaz J., Hachinski V., et al. Aggregation of multiple risk factors for stroke in siblings of patients with brain infarction and transient ischemic attacks // Stroke. – 1986. – Vol. 17. – P. 1239–1242.
66.Dichgans M., Mayer M., Uttner I., et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases // Ann. Neurol. – 1998. – Vol. 44.
– P.731-739
67.Dobson S.R, Holden K.R., Nietert P.J., et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent Cerebrovascular events // Blood. - 2002. – Vol.99. – P.3144-3150.
68.Doggen C.J., Cats V.M., Bertina R.M., et al. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A // Circulation. – 1998. – Vol.97. – P.1037–1041.
69.Elbaz A., Mallet C., et al. Association between the ACE 4656 (CT)2/3 polymorphism and plasma ACE level with lacunar stroke in the GENIC study // Cerebrovasc. Dis. – 1998. – Vol. 8. - Suppl 4. – P.13.
70.Ercan B., Tamer L., Sucu N., Pekdemir H., Camsari A., Atik U. Free Full Text Factor V Leiden and Prothrombin G20210A Gene Polymorphisms in
151
Patients with Coronary Artery Disease // Yonsei. Med. J. – 2008. – Vol.49. - №2. – P.237-243.
71.Esen F.I., et al. Glycoprotein Ib-alpha Kozak polymorphism in ischemic stroke // Neurol. Res. – 2012. – Vol.34. - №1. – P.68-71.
72.Ferraris D., Ficco R.P., Dain D., et al. Design and synthesis of poly(ADPribose) polymerase-1 (PARP-1) inhibitors // Bioorg. Med. Chem. – 2003. – Vol. 15. – Pt. 11. - №17ю – P.3695-3707.
73.Flossman E., Schulz U. G., Rothwell P.M. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke // Stroke. - 2004. - Vol.35. - P. 212-227.
74.Franco, R.F.; Trip, M.D., ten Cate, H., van den Ende, A., Prins, M.H., Kastelein, J.J.P., Reitsma, P.H. The 20210G-A mutation in the 3-prime- untranslated region of the prothrombin gene and the risk for arterial thrombotic disease // Brit. J. Haemat. – 1999. – Vol.104. – P.50-54.
75.Frank M.B., Reiner A.P., Schwartz S.M., Kumar P.N., Pearce R.M., Arbogast P.G., Longstreth W.T. Jr, Rosendaal F.R., Psaty B.M., Siscovick D.S. The Kozak sequence polymorphism of platelet glycoprotein Ibalpha and risk of nonfatal myocardial infarction and nonfatal stroke in young women // Blood. – 2001. Vol. 97. – P. 4875-4879.
76.Friso S., Choi S., Girelli D. A common mutation in the 5,10methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status // Proc. Natl. Acad. Sci. USA. -2002. – Vol. 99. - P. 5606-5611.
77.Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase // Nat. Genet. – 1995. – Vol.10. - №1.
– P.111-113.
152
78.Fukui M., Kono S., Sueishi K., Ikezaki K. Moyamoya disease // Neuropathology. – 2000. – Vol. 20. – P.61-64.
79.Ganesan V., McShane M.A., Liesner R., Cookson J., Hann I., Kirkham F.J. Inherited prothrombotic states and ischaemic stroke in childhood // J. Neurol. Neurosurg. Psychiatry. – 1998. – Vol. 65. – P. 508-511.
80.Geng Y.J., Ubby P. Evidence for Apoptosis in Advanced Human Atheroma. Colocalization with Interleukin-Ip-Converting Enzyme // Am. J. Pathol. – 1995. – Vol. 147. - №2. – P.251-266.
81.Gonzalez-Conejero R., Lozano M.L.,Rivera J., et al. Polymorphisms of platelet membrane glycoprotein Ib associated with arterialthrombotic disease // Blood. – 1998. – Vol.92. P.2771-2776.
82.Goto S., Xue R., Sugo N., et al. Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery // Stroke. – 2002. – Vol. – 33. -
№4.b- P.1101-1106.
83.Goyette P., Summer J., Milos R. et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification // Nat. Genet. - 1994.- Vol. 7.- P.195-200
84.Graham M., Daly L., Refsum H., et al. Plasma homocysteine as a risk factor for vascular disease: the European concerted action project // JAMA. – 1997. – Vol. 277. - №22. – P. 1775–1781.
85.Grewal R.P. Stroke in Fabry's disease // J. Neural. – 1994. – Vol. 241. – P.153-156.
86.Günther G., Junker R., Sträter R., Schobess R., Kurnik K., Kosch A.,
Nowak-Göttl U., for the Childhood Stroke Study Group. Symptomatic ischemic stroke in full-term neonates. Role of acquired and genetic prothrombotic risk factors // Stroke. – 2000. – Vol.31. – P.2437-2441.
87.Gupta N., Khan F., Tripathi M., Singh V.P., Tewari S., Ramesh V., Sinha N., Agrawal S. Absence of factor V Leiden (G1691A) mutation, FII
153
G20210A allele in coronary artery disease in North India // Indian J. Med. Sci. – 2003. – Vol. 57. - №12. – P.535-542.
88.Halbmayer W-M., Haushofer A., Hermann K-M., Fischer M. The 20210A allele of the prothrombin gene: a risk factor for juvenile stroke? A result of a pilot study // Blood Coag. Fibrinol. – 1998. – Vol. 9. – P. 209-212.
89.Hamedani A.G., Cole J.W., Mitchell B.D., Kittner S.J. Meta-analysis of factor V Leiden and ischemic stroke in young adults: the importance of case ascertainment // Stroke. – 2010. – Vol. 41. - №8. – P.1599-15603.
90.Han D.K.M., Haudenschild C.C., Hong U.K., et al. Evidence for Apoptosis in Human Atherogenesis and in a Rat Vascular Injury Model // Am. J. Pathol. – 1995. – Vol.147. - №2. – P.267-277.
91.Handa M., Titani K., Holland L.Z., et al. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments // J. Biol. Chem. – 1986. – Vol. 261. – P.1257912585.
92.Hankey G.J., Eikelboom J.W., van Bockxmeer F.M., Lofthouse E., Staples N., Baker R.I. Inherited thrombophilia in ischemic stroke and its subtypes // Stroke. – 2001. – Vol. 32. – P. 1793-1799.
93.Hassan A., Marcus H. Genetics and ischemic stroke // Brain. – 2000. – Vol.123. – P.1784–1812.
94.Heller C., Becker S., Scharrer I., Kreuz W. Prothrombotic risk factors in childhood stroke and venous thrombosis // Eur. J. Pediatr. – 1999. – Vol.158. – P.117-121.
95.Hirano M., Pavlakis S.G. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts // J. Child Neural. – 1994. – Vol. 9. – P.4-13.
96.Hogenesch J.B., Chan W.K., Jackiw V.H., Brown R.C., et al.
Characterization of a subset of the basic-helix-loop-helix-PAS superfamily 154
that interacts with components of the dioxin signaling pathway // J. Biol. Chem. – 1997. – Vol.272. – P.8581-8593.
97.Hsu H., Xiong J. The TNF receptor 1-associated protein TRADD signals cell death and NF-kB activation // Cell. – 1995. – Vol. 81. – P. 495–504.
98.Huang L.E., Gu J., Schau M., Bunn H.F. Regulation of hypoxia-inducible factor 1A is mediated by an O2-depended degradation domain via the ubiquitin-proteasome pathway // Proc. Natl. Acad. Sci. USA. – 1998. – Vol.95. – P.7987-7992.
99.Inamoto N., Katsuya T., Kokubo Y., Mannami T., Asai T., Baba S., Ogata J., Tomoike H., Ogihara T. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population // Stroke. – 2003. – Vol.34. - №7. – P.1628-1633.
100. Isner J.M., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis // Circulation. – 1995. – Vol.91. - №11. –
P.2703-2711.
101. Iwai N., Tamaki C., Ohmichi N., Kinoshita M. The I/I genotype of the ACE gene delays the onses of acute coronary syndromes // J. Arteriosclerosis Thrombosis and Vascular Biology. – 1997. – Vol.171. -
№9. – P. 1730–1733.
102. Iyer N.V., Kotch L.E., Agani F., et al. Cellular and developmental control of O2 of hypoxia-inducible factor 1A // Genes & Dev. – 1998. – Vol.12. – P.149-162.
103. James F. Meshia, Thomas G. Brott, and Robert D. Brown. Genetics of Cerebrovascular Disorders // Mayo Clinic Proceedings. – 2005. – Vol.80. -
№1. – P.122-132
104. Jen J., Cohen A.H., Yue Q. et al. Hereditary Endotheliopathy with Retinopathy, Nephropathy, and Stroke (HERNS) // Neurology. - 1997. -
Vol. 49. - P. 1322-1330.
155
105.Jerrard-Dunne P., Cloud G., Hassan A., Marcus H.S. Evaluating the genetic component of ischemic stroke subtypes: a family history study // Stroke. - 2003. - Vol. 34. - P. 1364-1369.
106.Jilma-Stohlawetz P., Homoncik M., Jilma B. et al. Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates // British S.Haematol. - 2003. - Vol.120. - P.652-655
107.Jin K.L., Mao X.O., Nagayama T., et al. Induction of vascular endothelian growth factor and hypoxia-inducible factor 1A by global ischaemia in rat brain // Neuroscience. – 2000. – Vol.99. – P.577-585.
108.Jousilahti P., Rastenyte D. et al. Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14371 middle-aged men and women in Finland. Stroke 1997; 28: 136–146.
109.Joutel A., Andreux F., Gaulis S., et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients // J. Clin. Invest. – 2000. – Vol.105. – P.597-605
110.Joutel A., Corpechot C., Ducros A., et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia // Nature. – 1996. – Vol. 383. – P.707-710.
111.Joutel A., Dodick D.D., Parisi J.E., Cecillon M., Toumier-Lasserve E., Bousser M.G. De novo mutation in the Notch3 gene causing CADASIL // Ann. Neurol. – 2000. – Vol.47. – P.388-391.
112.Joutel A., Favrole P., Labauge P., et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis // Lancet. –
2001. – Vol. 358. – P. 2049-2051.
113. Joutel A., Vahedi K., Corpechot C., et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients // Lancet. – 1997. – Vol.350. – P.1511-1515.
156
114.Jurgensmeie J., et al. Bax directly induces release of citochrome C from isolated mitochondria // Proc. Natl. Acad. Sci. USA. – 1998. – Vol. 95. – P. 4997–5002.
115.Kallio P.J., Wilson W.J., O Brien S., et al. Regulation of hypoxiainducible transcription factor 1A by the ubiquitin-proteasome pathway // J. Biol. Chem. – 1999. – Vol. 274. – P.6519-6525.
116.Kandzari D.E., Goldschmidt-Clermont P.J. Platelet polymorphisms and ischemic heart disease: moving beyond traditional risk factors // J. Am. Coll. Cardiol. – 2001. – Vol. 38. – P.1028-1032
117.Kannan P., Yu Y., Wankhade S., Tainsky M.A. PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation // Nucleic. Acids. Res. – 1999. – Vol.27. – P.866-874.
118.Kaski S., Kekomaki R., Partanen J. Systemic screening for genetic polymorphism in human platelet glycoprotein Ib-alpha // Immunogenetics.
– 1996. - Vol. 44. – P.170-176.
119.Kawamoto R., Kohara K., Oka Y., Tomita H., Tabara Y., Miki T. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and ischemic stroke // J. Stroke Cerebrovasc. Dis. – 2005. –
Vol.14. - №2. – P.67-74.
120.Kelly P.J., Rosand J., Kistler J.P., Shih V.E., Silveira S., Plomaritoglou A., Furie K.L. Homocysteine, MTHFR 677C-T polymorphism, and risk of ischemic stroke: results of a meta-analysis // Neurology. – 2002. – Vol. 59. – P. 529-536.
121.Kenet G., Sadetzki S., Murad H., Martinowitz U., Rosenberg N., Gitel S., Rechavi G., Inbal A. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children // Stroke. – 2000.
–Vol. 31. – P. 1283-1288.
122.Kenny D., Muckian C., Fitzgerald D.J., Cannon C.P., Shields D.C.
Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent 157
ischaemic events in acute coronary syndrome patients // J. Thromb.
Thrombolysis. – 2002. – Vol.13. - №1. – P.13-19.
123.Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics // Br. J. Cancer. // 1972. – Vol.26. - №4. – P.239-257.
124.Killy D., Wolf P., Cupples A., Beiser A., Myers R. Familial aggregation of stroke the Framingham study // Stroke. – 1993. – Vol. 24. -
№9. – 1366-1371.
125. Kirschner L.S., Sandrini F., Monbo J., Lin J.P., Carney J.A., Stratakis C.A. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex // Hum. Mol. Genet. – 2000. – Vol.9. – P.3037-3046.
126. Kitazawa M., Anantharam V., Kanthasamy A., Kanthasamy A.G. Dieldrin promotes proteolytic cleavage of poly(ADP-ribose) polymerase and apoptosis in dopaminergic cells: protective effect of mitochondrial antiapoptotic protein Bcl-2 // Neurotoxicology. – 2004. – Vol.25. - №4. –
P.589-598.
127.Klerk M., Verhoef P., Clarke R., Blom H. J., Kok F. J., Schouten E. G. MTHFR Studies Collaboration Group : MTHFR 677C-T polymorphism and risk of coronary heart disease: a meta-analysis // JAMA. – 2002. – Vol. 288. – P. 2023-2031.
128.Kluck R., et al. The release of cytochrome C from mitochondria: a primary site for bcl-2 regulation of apoptosis // Science. – 1997. – Vol. 275.
– P.1132–1136.
129.Ko C.H., Lam C.W., Tse P.W., Kong C.K., Chan A.K., Wong L.J. De novo mutation in the mitochondrial tRNALeu(UUR) gene (A3243G) with rapid segregation resulting in MELAS in the offspring // J. Paediatr. Child Health. – 2001. – Vol. 37. – P.87-90.
158
130.Kozak M. Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes // Nucleic. Acids Res. – 1981.
– Vol.9. – P. 5233-5262.
131.Kuijpers R.W.A.M., Faber N.M., Cuypers H.T.M., et al. NH2terminal globular domain of human platelet glycoprotein Iba has a methionine145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens // J. Clin. Invest. - 1992. - Vol. 89. - P. 381–384.
132.Kuroki S., Ikeda U., Maeda Y. et al. Lack of association between the Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme Gene and vasoapastic angins // J. Clin. Cardiol. – 1997. – Vol.20. – P.873–
876.
133.Lane D.A., Grant P.J. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease // Blood. – 2000. – Vol.95. – P. 1517-1532.
134.Lardelli M., Dahlstrand J., Lendahl U. The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium // Mech. Dev. – 1994. – Vol. 46.
– P.123-136.
135.Leduc Y., Lawrence J.J., de Murcia G., Poirier G.G. Cell cycle regulation of poly(ADP-ribose) synthetase in FR3T3 cells // Biochem. Biophys. Acta. – 1988. – Vol.968. – P.275-282.
136.Lefkovits J., Plow E.F., Topol E.J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine // N. Engl. Med. - 1995. - Vol. 332. - P. 1553–1559.
137.Lindahl T., Satoh M.S., Poirier G.G., Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks // Trends Biochem. Sci. – 1995. – Vol.20. – P.405-411.
159
138. Lithgow T., et al. The protein product of the oncogene bcl-2 is a component of the nuclew envelope the endoplasmic reticulum and the often mitochondrial membrane // Cell Growth Differ. – 1994. – Vol. 5. – P. 411– 417.
139. Longstreth W.T., Jr, Rosendaal F.R., Siscovick D.S., et al. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A) // Stroke. – 1998. – Vol.29. – P.577–580.
140. Lopaciuk S., Bykowska K., Kwiecinski H., Mickielewicz A., Czlonkowska A., Mendel T., Kuczynska-Zardzewialy A., Szelagowska D.,
Winkyka J., Schröder W., Herrmann F.H., Jedrzejowska H. Factor V
Leiden, prothrombin gene G20210A variant, and methylentetrahydrofolatereductase C677T genotype in young adults with ischemic stroke // Clin. Appl. Thromb. Hemost. – 2001. – Vol. 7. – P. 346350.
141.Lopez J.A. The platelet glycoprotein Ib-IX complex // Blood Coagul. Fibrinolysis. – 1994.- Vol. 5. – P. 97-119
142.Lopez J.A., Ludwig E.H., McCarthy B.J. Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucinlike macroglycopeptide region. Structure/function implications // J. Biol. Chem. – 1992. – Vol. 267. –
P.10055-10061.
143.Lowe S., et al. P53 is regulator for radiation-induced apoptosis in mouse thymocytes // Nature. – 1993. – Vol.362. – P. 847–849.
144.Lusis A.J., Mar R., Pajukanta P. Genetics of atherosclerosis // Annu. Rev. Genomics Hum. Genet. - 2004. - Vol.5. - P. 189-218.
145.Mahoney F.I., Bartel D.W. Functional evaluation: THE BARTHEL INDEX // Md. State Med. J. – 1965. – Vol.14. – P.61-65.
160